Gene Therapy for X-linked Chronic Granulomatous Disease (X-CGD)
NCT01855685
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class
Stopped
Last patient withdrawed from the study.
Conditions
X-Linked Chronic Granulomatous Disease
Interventions
GENETIC:
X vivo gene therapy
Sponsor
Genethon